Phase Ib/II Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 08 Jan 2018
Price : $35 *
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer; Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jan 2018 Status changed from not yet recruiting to recruiting.
- 28 Sep 2017 Planned initiation date changed from 31 Aug 2017 to 31 Oct 2017.